Design a functional prototype of a new ultrasonic vascular sealing technology as proof-of-concept for use in initial clinical trials.
Stratos provided R&D, staffing, technical and administrative support, facilities and funding that the company needed to accelerate the proof-of-concept development of its TheraSeal System.
TheraSeal is in Phase I clinical trials and is a unique, noninvasive ultrasound device for sealing femoral artery punctures following angiography and other catheter-based cardiology procedures.
Note: The TheraSeal System is an investigational device and is not currently available for sale or use in any country.